Cytosorbents
CTSO
#9873
Rank
A$60.22 M
Marketcap
A$0.96
Share price
-2.01%
Change (1 day)
-39.45%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$20.21 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.97 Million. In 2024 the company made an earning of -A$32.48 Million, an increase over its 2023 earnings that were of -A$41.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$20.21 Million-37.78%
2024 -A$32.48 Million-22.49%
2023 -A$41.9 Million-13.52%
2022 -A$48.45 Million34.04%
2021 -A$36.15 Million182.17%
2020 -A$12.81 Million-55.97%
2019 -A$29.09 Million14.17%
2018 -A$25.48 Million95.14%
2017 -A$13.06 Million-22.32%
2016 -A$16.81 Million39.1%
2015 -A$12.09 Million-12.89%
2014 -A$13.87 Million89%
2013 -A$7.34 Million26.65%
2012 -A$5.8 Million-26.02%
2011 -A$7.84 Million-288.45%
2010 A$4.15 M-4.17%
2009 A$4.33 M-287.19%
2008 -A$2.32 Million-47.12%
2007 -A$4.39 Million41.78%
2006 -A$3.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$4.67 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.14 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
A$79.3 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA